INTERLINKED AB

Their core work

INTERLINKED AB is a Swedish medical device SME developing safety hardware for intravenous (IV) therapy — the tubes, connectors, and flow-monitoring devices that deliver medication directly into a patient's bloodstream. Their core invention is a "break-away" safety connector that disconnects cleanly if an IV line is accidentally pulled, preventing injury to patients and protecting nurses from exposure to toxic drugs like chemotherapy agents. They also build devices to remove air bubbles from infusion lines (preventing embolism) and remote flow-rate monitors for home-care settings. In short: they make IV therapy safer for both the person receiving it and the person administering it.

What they specialise in

How they've shifted over time

INTERLINKED's H2020 activity begins in 2020 with ReLink, addressing the mechanical problem of accidental IV-line dislodgement, with strong emphasis on pediatric and oncology patients and on nurse exposure to toxic drugs. The 2021 SAFE-Infusion project keeps the same occupational-safety anchor but extends the scope to closed-system transfer devices, bubble aspirators for embolism prevention, and remote flow-rate monitoring for home care. The shift is from a single in-hospital safety problem toward a broader IV-safety product family spanning hospital and home-care use.

They are moving from a single hospital-use safety connector toward a broader IV-safety product family that covers home-care monitoring and hazardous-drug handling — a good fit for partners in telehealth, oncology logistics, or hospital-at-home programs.

How they like to work

They coordinated both projects themselves — unusual for a small company and a signal that they own the core IP and set the technical direction. With only five unique partners across three countries over two projects, they clearly prefer compact, commercially-driven consortia over large academic networks. A partner joining them should expect focused product-development work rather than broad research exploration.

Small, focused network of 5 partners across 3 countries, built around their own product development rather than broad research collaboration. Geographic center is Sweden with selected European partners.

What sets them apart

INTERLINKED is a rare SME that coordinates EU innovation projects on its own — and does so specifically in the underserved niche of IV therapy hardware safety, a space dominated by large medtech firms with legacy products. Their value is not research breadth but a concrete, patentable product line (break-away connectors, bubble aspirators, flow monitors) that addresses documented clinical harm. For a partner, they offer a route into a mature medical device market with a differentiated safety angle.

Highlights from their portfolio

• ReLink
  Their flagship project at EUR 1.74M — a single-SME coordinated IA grant to bring a break-away IV connector to market, with explicit pediatric and oncology use cases.
• SAFE-Infusion
  Extends the safety platform beyond dislodgement into air-embolism prevention and remote monitoring for home IV therapy, showing a clear product-family strategy.